Proscia

Proscia is transforming cancer diagnosis and research with its AI-powered computational pathology software. Their Concentriq digital platform allows physicians and health-care professionals to leverage new data not previously visible to the human eye. As a result, the company is improving patient outcomes and accelerating the development of lifesaving cancer treatments.Top investors include Flybridge Capital Partners and Robin Hood Ventures.